Rashed Dewan
Vermögen: 586 470 $ am 31.05.2026
Vermögen: 586 470 $ am 31.05.2026
Rashed Dewan is currently Chief Financial Officer at Profound Medical Corp.
since 2022.
Formerly, Mr. Dewan worked as Controller at Profound Medical, Inc. Mr. Dewan completed undergraduate studies at the University of Southern California.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
PROFOUND MEDICAL CORP 0,24 % | 24.06.2026 | 86.119 ( 0,24 % ) | 586 470 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| PROFOUND MEDICAL CORP. | Finanzdirektor/CFO | 03.03.2022 |
| Unternehmen | Position | Ende |
|---|---|---|
Profound Medical, Inc.
Profound Medical, Inc. Medical SpecialtiesHealth Technology Develops and commercializes a unique, minimally invasive treatment for prostate cancer | Comptroller/Controller/Auditor | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 3 |
|---|---|
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Profound Medical, Inc.
Profound Medical, Inc. Medical SpecialtiesHealth Technology Develops and commercializes a unique, minimally invasive treatment for prostate cancer | Health Technology |
Profound Medical Corp.
Profound Medical Corp. Medical SpecialtiesHealth Technology Develops and markets medical devices focused on prostate cancer | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen